Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-11-14

FDA Approved: LUZU — Original Application (Bausch Health US, LLC)

View source ↗

Summary

FDA approved LUZU (luliconazole) as a topical antifungal for the treatment of superficial fungal infections of the skin caused by dermatophytes, including tinea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUZU (luliconazole)

Snippet

ORIG AP for LUZU (LULICONAZOLE)